Policy/Regulatory

sunosi
Sleep Pharmaceuticals Policy/Regulatory Product/Vendor Updates

Axsome Drops Sunosi Patent Litigation Against Sandoz Generic

Axsome Therapeutics, Inc. announced that it has reached an agreement with Sandoz Inc. (Sandoz) to dismiss the patent litigation related to Axsome’s product Sunosi® (solriamfetol). The litigation, which was pending in the United States District Court for the District of New Jersey, resulted from submission by Sandoz of an Abbreviated New Drug […]

vanda loses patent
Policy/Regulatory

Vanda Loses Patents on Hetlioz Sleep Drug

  Vanda Pharmaceuticals Inc. today responded to the ruling in its Hetlioz® Abbreviated New Drug Application appeal. Today a three-judge panel of the United States Court of Appeals for the Federal Circuit issued a written opinion that affirmed a December 13, 2022, decision of the United States District Court for the District of Delaware, […]

sleep health caucus
Policy/Regulatory AASM

AASM Establishes Congressional Sleep Health Caucus

The American Academy of Sleep Medicine has established a Congressional Sleep Health Caucus to emphasize the necessity of healthy sleep for optimal health and promote high-quality, patient-centered care for the millions of Americans who have sleep disorders. Congressional caucuses are political groups comprising Senate and House members who periodically meet […]